Dexlansoprazole and Swallowing difficulty - a phase IV clinical study of FDA data
Swallowing difficulty is found among people who take Dexlansoprazole, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Dexlansoprazole and have Swallowing difficulty. It is created by eHealthMe based on reports of 2,304 people who have side effects when taking Dexlansoprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,304 people reported to have side effects when taking Dexlansoprazole.
Among them, 30 people (1.3%) have Swallowing difficulty.
What is Dexlansoprazole?
Dexlansoprazole has active ingredients of dexlansoprazole. eHealthMe is studying from 2,313 Dexlansoprazole users for its effectiveness, alternative drugs and more.
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 3,632 drugs and 3,210 conditions by eHealthMe.
Number of Dexlansoprazole and Swallowing difficulty reports submitted per year:
Gender of people who have Swallowing difficulty when taking Dexlansoprazole *:
- female: 38.46 %
- male: 61.54 %
Age of people who have Swallowing difficulty when taking Dexlansoprazole *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 4.55 %
- 30-39: 0.0 %
- 40-49: 31.82 %
- 50-59: 22.73 %
- 60+: 40.91 %
Common drugs people take besides Dexlansoprazole *:
- Pantoprazole: 9 people, 30.00%
- Benadryl: 7 people, 23.33%
- Calcium: 6 people, 20.00%
- Nexium: 6 people, 20.00%
- Prilosec: 6 people, 20.00%
- Dexilant: 5 people, 16.67%
- Tylenol: 5 people, 16.67%
- Fish Oil: 5 people, 16.67%
- Septra: 5 people, 16.67%
- Prevacid: 4 people, 13.33%
Common side effects people have besides Swallowing difficulty *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 23.33%
- Joint Pain: 7 people, 23.33%
- Weight Increased: 5 people, 16.67%
- Interstitial Lung Disease: 5 people, 16.67%
- Fever: 5 people, 16.67%
- Heart Rate Increased: 5 people, 16.67%
- Pulmonary Function Test Decreased: 5 people, 16.67%
- Inflammatory Marker Increased: 5 people, 16.67%
- Breathing Difficulty: 5 people, 16.67%
- Incontinence (lack of moderation or self-control): 4 people, 13.33%
Common conditions people have *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.00%
- Hypersensitivity: 4 people, 13.33%
- Bone Disorder: 4 people, 13.33%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 4 people, 13.33%
- Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 10.00%
- Malignant Melanoma (skin cancer rises from melancytes): 2 people, 6.67%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 6.67%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 6.67%
- Depression: 2 people, 6.67%
- High Blood Pressure: 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Dexlansoprazole and have Swallowing difficulty?Check whether Swallowing difficulty is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Swallowing difficulty and when was it recovered:
Expand to all the drugs that have ingredients of dexlansoprazole:
Alternative drugs to, pros and cons of Dexlansoprazole:
- Dexlansoprazole (2,313 reports)
Common Dexlansoprazole side effects:
- Chronic kidney disease: 402 reports
- Acute kidney failure: 184 reports
- Drug ineffective: 168 reports
- Fatigue (feeling of tiredness): 158 reports
- Pain: 142 reports
- High blood pressure: 131 reports
- Diarrhea: 123 reports
- Breathing difficulty: 119 reports
- Dizziness: 114 reports
Browse all side effects of Dexlansoprazole:a b c d e f g h i j k l m n o p q r s t u v w x y z
Swallowing difficulty treatments and more:
- Swallowing difficulty (98,418 reports)
COVID vaccines that are related to Swallowing difficulty:
- Swallowing difficulty in Moderna COVID Vaccine
- Swallowing difficulty in Pfizer BioNTech Covid Vaccine
- Swallowing difficulty in Johnson and Johnson Covid Vaccine
Common drugs associated with Swallowing difficulty:
- Aspirin: 4,818 reports
- Prednisone: 4,430 reports
- Omeprazole: 3,202 reports
- Lisinopril: 2,813 reports
- Nexium: 2,643 reports
- Synthroid: 2,587 reports
- Fosamax: 2,524 reports
- Gabapentin: 2,402 reports
- Methotrexate: 2,384 reports
- Lipitor: 2,354 reports
All the drugs that are associated with Swallowing difficulty:
- Swallowing difficulty (3,632 drugs)
Common conditions associated with Swallowing difficulty:
- High blood pressure: 4,824 reports
- Multiple sclerosis: 3,962 reports
- Pain: 3,308 reports
- Depression: 2,699 reports
- Parkinson's disease: 2,677 reports
- Osteoporosis: 2,629 reports
All the conditions that are associated with Swallowing difficulty:
- Swallowing difficulty (3,210 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dexlansoprazole (the active ingredients of Dexlansoprazole) and Dexlansoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cymbalta and Speech Disorder - 2 seconds ago
- Cyclophosphamide and Thrombophlebitis - 4 seconds ago
- Taxotere and Pulmonary Thrombosis - 6 seconds ago
- Taxotere and Punctate Keratitis - 7 seconds ago
- Mirtazapine and Alcohol drug interaction - 8 seconds ago
- Epoprostenol Sodium and Sleep Walking - 8 seconds ago
- Cozaar and Blood Magnesium Abnormal - 8 seconds ago
- Crestor and Nephropathy Toxic - 9 seconds ago
- Lupron and Myasthenia Gravis - 11 seconds ago
- Crestor and Nail Ridging - 11 seconds ago